Convection-Enhanced Delivery

Precision NeuroMed Earns FDA Orphan Drug Status for GBM Therapy

REDWOOD CITY, Calif., Oct. 7, 2025 — Precision NeuroMed (PNM), a clinical-stage biotechnology company advancing next-generation drug delivery technologies...

By cGxPwire Editor
October 7, 2025

We work Hard to get you posted with latest updates

Unwrap our new Directory

Convection-Enhanced Delivery

Precision NeuroMed Earns FDA Orphan Drug Status for GBM Therapy